| pubmed-article:11909706 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:11909706 | lifeskim:mentions | umls-concept:C0003392 | lld:lifeskim |
| pubmed-article:11909706 | lifeskim:mentions | umls-concept:C0596402 | lld:lifeskim |
| pubmed-article:11909706 | lifeskim:mentions | umls-concept:C0220781 | lld:lifeskim |
| pubmed-article:11909706 | lifeskim:mentions | umls-concept:C1883254 | lld:lifeskim |
| pubmed-article:11909706 | lifeskim:mentions | umls-concept:C0053169 | lld:lifeskim |
| pubmed-article:11909706 | lifeskim:mentions | umls-concept:C0243072 | lld:lifeskim |
| pubmed-article:11909706 | pubmed:issue | 7 | lld:pubmed |
| pubmed-article:11909706 | pubmed:dateCreated | 2002-3-22 | lld:pubmed |
| pubmed-article:11909706 | pubmed:abstractText | A new series of trans-stilbene benzenesulfonamide derivatives were designed and synthesized as potential antitumor agents. These new compounds were evaluated in the National Cancer Institute's 60 human tumor cell line in vitro screen. Compounds 9-13 were cytotoxic against several cell lines. Notably, two compounds, 9 and 12, demonstrated selective cytotoxic activity against BT-549 breast cancer (GI(50)=0.205 microM) and HT-29 colon cancer (GI(50)=0.554 microM), respectively. | lld:pubmed |
| pubmed-article:11909706 | pubmed:language | eng | lld:pubmed |
| pubmed-article:11909706 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:11909706 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:11909706 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:11909706 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:11909706 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:11909706 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:11909706 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:11909706 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:11909706 | pubmed:month | Apr | lld:pubmed |
| pubmed-article:11909706 | pubmed:issn | 0960-894X | lld:pubmed |
| pubmed-article:11909706 | pubmed:author | pubmed-author:YangLi-MingLM | lld:pubmed |
| pubmed-article:11909706 | pubmed:author | pubmed-author:LinShwu-Jiuan... | lld:pubmed |
| pubmed-article:11909706 | pubmed:author | pubmed-author:HsuFen-LinFL | lld:pubmed |
| pubmed-article:11909706 | pubmed:author | pubmed-author:YangTsang-Hsi... | lld:pubmed |
| pubmed-article:11909706 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:11909706 | pubmed:day | 8 | lld:pubmed |
| pubmed-article:11909706 | pubmed:volume | 12 | lld:pubmed |
| pubmed-article:11909706 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:11909706 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:11909706 | pubmed:pagination | 1013-5 | lld:pubmed |
| pubmed-article:11909706 | pubmed:dateRevised | 2006-11-15 | lld:pubmed |
| pubmed-article:11909706 | pubmed:meshHeading | pubmed-meshheading:11909706... | lld:pubmed |
| pubmed-article:11909706 | pubmed:meshHeading | pubmed-meshheading:11909706... | lld:pubmed |
| pubmed-article:11909706 | pubmed:meshHeading | pubmed-meshheading:11909706... | lld:pubmed |
| pubmed-article:11909706 | pubmed:meshHeading | pubmed-meshheading:11909706... | lld:pubmed |
| pubmed-article:11909706 | pubmed:meshHeading | pubmed-meshheading:11909706... | lld:pubmed |
| pubmed-article:11909706 | pubmed:meshHeading | pubmed-meshheading:11909706... | lld:pubmed |
| pubmed-article:11909706 | pubmed:meshHeading | pubmed-meshheading:11909706... | lld:pubmed |
| pubmed-article:11909706 | pubmed:meshHeading | pubmed-meshheading:11909706... | lld:pubmed |
| pubmed-article:11909706 | pubmed:meshHeading | pubmed-meshheading:11909706... | lld:pubmed |
| pubmed-article:11909706 | pubmed:meshHeading | pubmed-meshheading:11909706... | lld:pubmed |
| pubmed-article:11909706 | pubmed:meshHeading | pubmed-meshheading:11909706... | lld:pubmed |
| pubmed-article:11909706 | pubmed:meshHeading | pubmed-meshheading:11909706... | lld:pubmed |
| pubmed-article:11909706 | pubmed:meshHeading | pubmed-meshheading:11909706... | lld:pubmed |
| pubmed-article:11909706 | pubmed:year | 2002 | lld:pubmed |
| pubmed-article:11909706 | pubmed:articleTitle | Antitumor agents. Part 3: synthesis and cytotoxicity of new trans-stilbene benzenesulfonamide derivatives. | lld:pubmed |
| pubmed-article:11909706 | pubmed:affiliation | Division of Medicinal Chemistry, National Research Institute of Chinese Medicine, 155-1, Li-Nong St., Sec. 2, Taipei 112, Taiwan. lmyang@cma23.nricm.edu.tw | lld:pubmed |
| pubmed-article:11909706 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:11909706 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
| http://linkedlifedata.com/r... | http://linkedlifedata.com/r... | pubmed-article:11909706 | lld:chembl |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:11909706 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:11909706 | lld:pubmed |
